Clinical Trials Logo

Clinical Trial Summary

This study is an interventional, non-pharmacological, multicentric, randomized, controlled, superiority, non-profit study. Its primary objective is to evaluate if the administration of surfactant based on FOT assessment will allow a 5-day reduction in the duration of respiratory support as compared to standard practice in preterm infants between 27+0 and 32+6 weeks' gestation. The secondary objectives are: 1. to determine if a lung mechanics-based approach for administering surfactant will change treatment timing; and 2. to assess the impact of the novel approach on other neonatal general outcomes. The study will take place within the neonatal intensive care units. Non-invasive respiratory support will be delivered by nasal CPAP with a starting pressure of 5-8 cmH2O. FiO2 will be titrated in order to achieve the target SpO2 91-95%. Infants matching the clinical criteria for inclusion will be randomized in two arms following the current data protection and confidentiality regulations. Central, computer-generated randomization (allocation 1:1) with variable block sizes according to gestational age will be used. Infants will be stratified according to gestational age (27+0 -28+6 weeks; 29+0 -30+6 weeks; 31+0 -32+6 weeks) and center. Study Arms: A) Surfactant administration following oxygenation-based criteria (clinical assessment) (control) B) Surfactant administration following both lung mechanics assessment OR oxygenation-based criteria (clinical assessment) (intervention).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05791331
Study type Interventional
Source Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Contact
Status Not yet recruiting
Phase N/A
Start date May 18, 2023
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04016246 - Respiratory Effect of the LISA Method With Sedation by Propofol Versus Absence of Sedation. Phase 3
Enrolling by invitation NCT04118400 - Ventilator Weaning Outcome Between NIV-NAVA and Nasal CPAP (or IMV ) Modes in Premature Neonates
Completed NCT01941745 - Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome Phase 2
Not yet recruiting NCT04019106 - Budesonide With Intratracheal Surfactants in Extremely Preterm Infants Phase 1/Phase 2
Not yet recruiting NCT04862377 - Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia. Phase 3
Completed NCT04086095 - Feasibility Study - Neofact N/A
Not yet recruiting NCT05609877 - The NONA-LISA Trial N/A
Recruiting NCT04326270 - Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs N/A
Active, not recruiting NCT03969992 - A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact Phase 2
Completed NCT03700606 - Physiological Changes With High-Flow Nasal Cannula N/A
Recruiting NCT04359134 - Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distress.
Not yet recruiting NCT06229821 - Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants N/A
Recruiting NCT05446389 - PAL to Improve Oral Feeding for Infants With Chronic Lung Disease N/A
Withdrawn NCT04914715 - nHFOV Versus Invasive Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome N/A
Recruiting NCT03825835 - 30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants N/A
Recruiting NCT03562182 - Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
Completed NCT05031650 - Open Lung Strategy During Non-Invasive Respiratory Support of Very Preterm Infants in the Delivery Room N/A
Completed NCT03306524 - The Role of Circuit Flow During Mechanical Ventilation of Neonates N/A
Completed NCT01473264 - Safety, Pk and Anti-inflammatory Effects of CC10 Protein in Premature Infants With Respiratory Distress Syndrome (RDS) Phase 1/Phase 2
Completed NCT03548324 - Enteral Nutrition Tolerance And REspiratory Support (ENTARES) N/A